Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis

por Takahashi M, Flynn JA, Tanji Y, Ascher-Svanum H, Ye W, Conley RR
Publicado 2012

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection

por Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H
Publicado 2014

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

por Ascher-Svanum H, Brnabic AJM, Lawson AH, Kinon BJ, Stauffer VL, Feldman PD, Kelin K
Publicado 2012

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia

por Chen L, Ascher-Svanum H, Lawson A, Stauffer VL, Nyhuis A, Haynes V, Schuh K, Kinon BJ
Publicado 2013

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

por Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensl, MD, Ascher-Svanum H
Publicado 2014